Treatment of acute COVID-19 in the community
Australian Prescriber · 04.08.2026 · 49 (4) · 116-123
DOI: 10.18773/austprescr.2026.033 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Australian Prescriber, online erschienen am 04.08.2026. Verfasst von Eliza Milliken. Beteiligte Einrichtung: Hunter New England Health, New South Wales. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
COVID-19 infection in an otherwise healthy person is usually a mild to moderate self-limiting illness, but certain populations are at higher risk of severe disease (e.g. older age, severe immunocompromise, certain comorbidities). Adults with acute COVID-19 should be assessed for disease severity and underlying risk factors to guide appropriate management. Infection control, including case isolation, is important to reduce spread. Antiviral therapy is reserved for patients most likely to benefit, given its high cost, potential adverse effects and uncertain clinical benefit. Patients showing signs of severe or critical disease should be referred to hospital. Antiviral therapies are most effective when started within 5 days of symptom onset. Nirmatrelvir with ritonavir is the first-line antiviral for patients without contraindications, but it has extensive drug interactions. Molnupiravir is used when nirmatrelvir with ritonavir is unsuitable. Inhaled and oral glucocorticoids and immune therapies have no role in routine community treatment of mild to moderate COVID-19. Vaccination remains the single most effective intervention for reducing the risk of severe disease and should be actively encouraged, particularly in unvaccinated or vaccine-hesitant individuals.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hunter New England Health, New South Wales.
ORCID-Profile: Eliza Milliken
Zitieren
APA
Milliken, E. (2026). Treatment of acute COVID-19 in the community. Australian Prescriber, 49(4), 116-123. https://doi.org/10.18773/austprescr.2026.033
Vancouver
Milliken E. Treatment of acute COVID-19 in the community. Australian Prescriber. 2026;49(4):116-123. doi:10.18773/austprescr.2026.033
BibTeX
@article{Milliken2026,
author = {Milliken, Eliza},
title = {Treatment of acute COVID-19 in the community},
journal = {Australian Prescriber},
year = {2026},
volume = {49},
number = {4},
pages = {116--123},
doi = {10.18773/austprescr.2026.033}
}
EUVIMED